Myriad Genetics | MYGN - Ordinary Share Capital


Myriad Genetics reported $93.5M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 281.97M 252K Jun/2026
Becton, Dickinson and Co. USD 370.59M 95.05M Jun/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Bruker USD 152.35M 130K Jun/2026
Danaher USD 702.9M 4.8M Jun/2026
Illumina USD 151.3M 607K Jun/2026
J&J USD 2.41B 1.35M Mar/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quest Diagnostics USD 110M 1000K Jun/2026
Quidel USD 68.1M 200K Mar/2026
Repligen USD 56.43M 28K Jun/2026
Revvity USD 111.63M 174K Jun/2026
Standard Biotools USD 390.14M 3.76M Mar/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Veracyte USD 79.79M 1000 Jun/2026
Waters USD 98.19M 20K Jun/2026